CLOs on the Move

Baxter

www.baxter.com

 
Baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
  • Number of Employees: 10K-50K
  • Annual Revenue: > $1 Billion
  • www.baxter.com
  • 1 Baxter Parkway
    Deerfield, IL USA 60015
  • Phone: 800.422.9837

Executives

Name Title Contact Details
Edward Ryan
 Sr. Dir, IT, Office of CIO Profile
Annlea Rumfola
 EVP, Chief Information Officer Profile
Heather Knight
 Chief Operating Officer Profile
Chris Toth
 Chief Executive Officer Profile
Carl Jenkins
 Associate General Counsel, Legal-Regulatory Profile

Similar Companies

Healthline Systems Inc

Healthline Systems Inc is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Kinex Medical Company

Kinex Medical Company is a Waukesha, WI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Stereo Optical Co.

Stereo Optical Co., Inc. is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

EUROIMMUN US

EUROIMMUN US is a Boonton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cordis

With more than a 60-year history of pioneering products to treat millions of patients, Cordis is a worldwide leader in the development and manufacturing of interventional cardiovascular technology. Cordis established a legacy of high-quality and minimally-invasive cardiovascular products; and has built a robust global footprint with operations in more than 60 countries around the world. As from August 2, 2021, Cordis is a standalone company, and is committed to investing $300 million to accelerate innovation in its broad product portfolio. Building on our storied brand, we are unleashing our potential to be a $10 billion leader bringing new technology to the market through bold action at speed.